Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Cardiology Centres of the Netherlands | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
The goal of this observational study is to evaluate the implementation of a structured, digital, nurse-led, remote monitoring care pathway for cardiovascular risk management (CVRM). Participants will receive this care as part of routine clinical practice. In addition to standard follow-up, participants will complete questionnaires on quality of life, medication adherence, system usability, and patient satisfaction.
CVRM is essential for patients at increased risk of cardiovascular disease (CVD) as well as for those with established atherosclerotic cardiovascular disease (ASCVD). Monitoring blood pressure and lipid profiles is crucial to achieving guideline-recommended targets. However, many patients fail to reach these targets despite the availability of effective therapies, resulting in an increased risk of recurrent events. Meanwhile, the burden of CVD continues to rise, creating significant pressure on healthcare systems.
A digital care pathway may improve therapy adherence and outcomes by enabling personalized, data-driven care. This study evaluates the effectiveness of a nurse-led, telemonitoring pathway for CVRM in routine practice, where patients measure their blood pressure and LDL-c levels at home. The study aims to improve risk stratification, support earlier intervention, and optimize lipid and blood pressure control, ultimately leading to better patient outcomes.
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Number of patients on-target for LDL-c | Proportion of patients achieving guideline-recommended LDL-c targets | Baseline and 1 year |
| Measure | Description | Time Frame |
|---|---|---|
| Mean LDL-c | The mean of LDL-c values in mmol/L, measured at-home | Baseline and 1 year follow-up |
| Number of patients achieving blood pressure control | Proportion of patients achieving guideline-recommended blood pressure targets |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
All patients enrolled in the digital CVRM program will be invited to participate in this registry.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Youri Schut, MSc | Contact | +31205668051 | y.schut@amsterdamumc.nl |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Cardiology Centers of the Netherlands (CCN) | Amsterdam | North Holland | Netherlands |
Not provided
Not provided
Not provided
Not provided
| Baseline and 1 year |
| Change in home-measured blood pressure values | Change in blood pressure values measured at home with telemonitoring in mmHg | Baseline and 1 year |
| Number of medication changes | Changes in lipid-lowering and antihypertensive medications, defined as change in dose and change in medication type | 1 year |
| 5-item Medication Adherence Report Scale (MARS-5) | 5 questions about medication adherence, with higher scores indicating better adherence | Baseline and 1 year |
| Visual Analog Scale (VAS) for medication adherence | The scale ranges from 0% to 100%, with higher scores indicating better medication adherence | Baseline and 1 year |
| Quality of life (QoL) | Using the EuroQoL-5D questionnaire | Baseline and 1 year |
| Telehealth Usability Questionnaire (TUQ) | 18 questions on patient satisfaction and usability, with higher scores indicating better satisfaction | Baseline and 1 year |
| Hospitalization | Unplanned cardiovascular (re)hospitalization | 12 and 24 months |
| MACE | Cardiovascular death, myocardial infarction, any documented stroke (ischemic or hemorrhagic), ischemia-driven revascularization | 12 and 24 months |
| All-cause mortality | Total number of deaths from any cause | 12 and 24 months |
| ID | Term |
|---|---|
| D050197 | Atherosclerosis |
| D006973 | Hypertension |
| D050171 | Dyslipidemias |
| ID | Term |
|---|---|
| D001161 | Arteriosclerosis |
| D001157 | Arterial Occlusive Diseases |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D052439 | Lipid Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided